Literature DB >> 27385908

Dopamine transporter single-photon emission computed tomography brain scan: A reliable way to distinguish between degenerative and drug-induced parkinsonism.

Shakya Bhattacharjee1, Paramananda Vijaya Shankar2, Mohammed Elkider3.   

Abstract

Entities:  

Year:  2016        PMID: 27385908      PMCID: PMC4918501          DOI: 10.4103/0972-3919.183620

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN: 0974-0244


× No keyword cloud information.
Sir, A 54-year-old man on valproate because of bipolar affective disorders developed extra-pyramidal symptoms suggestive of drug-induced parkinsonism. His symptoms persisted despite stopping valproate. He had a dopamine transporter (DaT) scan and single-photon emission computed tomography (SPECT) scan. The DaT scan showed abnormality (Grade 1) [Table 1] in the right putaminal tracer uptake suggestive of degenerative parkinsonism instead of drug-induced parkinsonism [Figure 1a and b].[12]
Table 1

Type of dopamine scan tracer (123I-Ioflupane) uptake in the human basal ganglia

Figure 1

(a) Normal dopamine transporter single-photon emission computed tomography scan appearance, normal dopamine transporter scan appearance with head of the caudate nucleus appearing like a full stop (large arrow), and the putamen appearing like tail (small arrow). (b) Abnormal dopamine transporter scan in our patient: The left side is normal with normal putaminal tail (large arrow). The right side has abnormal tracer uptake - absence of putaminal tail, but the normal appearance of the caudate nucleus was like a full stop (small open arrow) (Type 1 abnormal uptake as per Benamer )[2]

Type of dopamine scan tracer (123I-Ioflupane) uptake in the human basal ganglia (a) Normal dopamine transporter single-photon emission computed tomography scan appearance, normal dopamine transporter scan appearance with head of the caudate nucleus appearing like a full stop (large arrow), and the putamen appearing like tail (small arrow). (b) Abnormal dopamine transporter scan in our patient: The left side is normal with normal putaminal tail (large arrow). The right side has abnormal tracer uptake - absence of putaminal tail, but the normal appearance of the caudate nucleus was like a full stop (small open arrow) (Type 1 abnormal uptake as per Benamer )[2] DaT is the presynaptic transmembrane protein of the dopaminergic synapses. It transports dopamine back to the presynaptic neurons from the synaptic cleft. 123I-ioflupane is a molecular imaging agent used in DaT imaging to demonstrate the location and concentration of DaTs in the synapses. Tc99m-TRODAT and F-18 FDOPA positron emission tomography scan can also assess the DaT activity and the integrity of the presynaptic nigrostriatal function.[3] DaT SPECT brain scan is helpful to distinguish between pre- (degenerative) and post-synaptic (such as drug-induced or vascular parkinsonism) parkinsonism.[4] DaT imaging is usually normal in postsynaptic parkinsonism, but abnormal in the presynaptic variety.[1] The degenerative presynaptic parkinsonism includes sub-types such as idiopathic Parkinson's disease, progressive supranuclear palsy, multiple system atrophy, Lewy body dementia, and corticobasal degeneration. Though this SPECT scan can distinguish between pre- and post-synaptic parkinsonism, it cannot distinguish among the sub-types of degenerative parkinsonism mentioned above.[14]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  4 in total

1.  Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.

Authors:  T S Benamer; J Patterson; D G Grosset; J Booij; K de Bruin; E van Royen; J D Speelman; M H Horstink; H J Sips; R A Dierckx; J Versijpt; D Decoo; C Van Der Linden; D M Hadley; M Doder; A J Lees; D C Costa; S Gacinovic; W H Oertel; O Pogarell; H Hoeffken; K Joseph; K Tatsch; J Schwarz; V Ries
Journal:  Mov Disord       Date:  2000-05       Impact factor: 10.338

2.  SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0.

Authors:  David S W Djang; Marcel J R Janssen; Nicolaas Bohnen; Jan Booij; Theodore A Henderson; Karl Herholz; Satoshi Minoshima; Christopher C Rowe; Osama Sabri; John Seibyl; Bart N M Van Berckel; Michele Wanner
Journal:  J Nucl Med       Date:  2011-12-08       Impact factor: 10.057

Review 3.  PET/CT in diagnosis of movement disorders.

Authors:  Valentina Berti; Alberto Pupi; Lisa Mosconi
Journal:  Ann N Y Acad Sci       Date:  2011-06       Impact factor: 5.691

Review 4.  Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes.

Authors:  Nin Bajaj; Robert A Hauser; Igor D Grachev
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-13       Impact factor: 10.154

  4 in total
  1 in total

1.  Dopamine transporter scan: A helpful yet underutilized tool to distinguish various subtypes of dementia.

Authors:  Shakya Bhattacharjee; Kher Lik Ng
Journal:  Indian J Nucl Med       Date:  2016 Oct-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.